BioAI Health
Seed
BioAI Health: Leveraging AI for improved disease diagnosis, therapy response prediction, and clinical trials.
Founded
2020BioAI Health: Leveraging AI for improved disease diagnosis, therapy response prediction, and clinical trials.
BioAI Health, founded with the mission to revolutionize precision medicine, leverages AI to enhance disease diagnosis and predict patient responses to therapies. The company's core vision is to integrate complex data from translational studies and clinical trials to develop advanced machine learning models on multi-omic data. BioAI Health offers a range of services including AI biomarker discovery, drug discovery, and biospecimen sourcing. Their market focus spans biopharma solutions, aiming to transform how diseases are understood and treated.
Notable figures affiliated with BioAI Health include leading experts in AI and biotechnology, though specific names are not disclosed. The company has garnered attention from prominent investors in the biotech and AI sectors. Key achievements include the development of their PredictX platform and in-silico phenotype projection technology, which have significantly impacted the field of precision medicine. BioAI Health's innovative approach has positioned it as a critical player in advancing personalized healthcare solutions.
Companies similar to BioAI Health include Precision Health AI, Gatc Health, Zephyr AI and Bayesian Health.
BioAI Health was founded in 2020.
BioAI Health's headquarters is located in Goffstown, NH, US.
BioAI Health's most recent funding round was for $3M (USD) in September 2022.
As of Sep 20, 2022, BioAI Health has raised a total of $3M (USD).
BioAI Health has 9 employees as of Feb 5, 2024.
Zephyr AI
zephyrai.bio
